Mortality of newly diagnosed heart failure treated with amiodarone A propensity-matched study.

Background: Studies on the safety of amiodarone therapy in heart failure (HF) presented conflicting results. We evaluated the relationship of commencing treatment with amiodarone (CTA) with the mortality and the morbidity of patients newly diagnosed with HF.

Methods: Prospective cohort study over 7 years on 3734 patients with HF.

Incidence and mortality of heart failure: a community-based study.

Background: Data on the incidence and mortality of heart failure (HF) in community-based populations of developed countries are limited. We estimated the trends of the incidence and, the mortality of HF.

Methods: Prospective population-based study in a white, low-middle class Mediterranean community of 267,231 inhabitants in Spain.